MedAlliance Enrolls First US Patient into its Third FDA IDE Study: SFA SELUTION4SFA
(Adnkronos) – GENEVA, May 5, 2023 /PRNewswire/ — The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr. Arthur Lee at the Cardiac & Vascular Institute in
